Lupin announced a sharp drop in consolidated net profit for the quarter ended June 2015. During the quarter, the profit of the company declined 15.96% to Rs 5,250.20 million from Rs 6,247.40 million in the same quarter last year.
Revenues for the quarter declined 5.70% to Rs 31,502.30 million, compared with Rs 33,408.00 million for the prior year period.
Operating margin for the quarter stood at 22.73 percent as compared to 30.12 percent for the previous year period. Operating Income for the quarter was Rs 7,159.40 million, compared with Rs 10061.7 million in the previous year period.
Earnings per share for the quarter stood at Rs 11.60, registering 16.37% decline over previous year period.
Nilesh Gupta, managing director, Lupin, said, ''Slowdown in approvals in the US dampened growth during the quarter, even as the Company continues to improve on gross margins. We remain focused on evolving our research pipeline, ensuring compliance, operational excellence and acquiring meaningful assets.''
| Quarterly Results - Consolidated (Rs in mn) |
| As at | Jun - 15 | Jun - 14 | %Change |
| Revenues | 31,502.30 | 33,408.00 | (5.70) |
| Net Profit | 5,250.20 | 6,247.40 | (15.96) |
| Diluted EPS | 11.60 | 13.87 | (16.37) |
Shares of the company declined Rs 95.45, or 5.23%, to trade at Rs 1,728.60. The total volume of shares traded was 472,550 at the BSE (3.46 p.m., Thursday).
